Engineering Microbes for Mucosal Drug Delivery
Tenza reprograms symbiotic bacteria from the human microbiome to administer medicines directly to the organs they naturally inhabit. We do so using a ML-powered, synthetic biology platform that enables us to engineer a wider diversity of bacteria to produce higher yields of drugs than ever before.
Tenza Team
Scientific Advisory Board
Rob Britton, Ph.D.
Wendy Garrett, M.D., Ph.D.
Steve Landau, M.D.
John March, Ph.D.
Hank Talbot, Ph.D.
Todd Zion, Ph.D.
Contact
700 Main St., Cambridge, MA, USA
George Church, Ph.D.
Co-founder
Anik Debnath, Ph.D.
Co-founder & CEO
Todd Krueger
Executive Director
Denise Sirias, Ph.D.
Principal Scientist
Ameet Shetty, Ph.D.
Principal Scientist
Devon Stork, Ph.D.
Principal Scientist